Abstract
The effects of 5-hydroxytryptamine on the blood pressure of anaesthetized rats depended on the dose and the initial level of blood pressure. At medium blood pressure levels, 5-hydroxytryptamine gave a depressor response and sometimes a pressor response which was more evident with large doses. The depressor effect was less apparent or even absent at low, and more pronounced at high, blood pressure levels, and the converse applied to the pressor components. Adenosine also gave a depressor and pressor response. Lysergic acid diethylamide, dihydroergotamine, 1-(3,4-dichlorophenyl)-2-isopropylaminoethanol (a dichloro analogue of isoprenaline), dibenamine and 1-benzyl-5-methoxy-2-methyltryptamine antagonized 5-hydroxytryptamine and catechol amines. Lysergic acid diethylamide and 1-benzyl-5-methoxy-2-methyltryptamine were more effective against 5-hydroxytryptamine, 1-(3,4-dichlorophenyl)-2-isopropylaminoethanol and dibenamine against catechol amines; dihydroergotamine was equally effective against both groups. These antagonists fell into two groups according to their action against the two types of effects (depressor and pressor) of 5-hydroxytryptamine: lysergic acid diethylamide and 1-(3,4-dichlorophenyl)2-isopropylaminoethanol acted preferentially against depressor effects; 1-benzyl-5-methoxy-2-methyltryptamine and dibenamine preferentially against pressor; dihydroergotamine was not assignable to either group. Adenosine was affected similarly, but less than 5-hydroxytryptamine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BORN G. V., INGRAM G. I., STACEY R. S. The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets. Br J Pharmacol Chemother. 1958 Mar;13(1):62–64. doi: 10.1111/j.1476-5381.1958.tb00191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CRAWFORD T. B. B., OUTSCHOORN A. S. The quantitative separation of adrenaline and noradrenaline in biological fluids and tissue extracts. Br J Pharmacol Chemother. 1951 Mar;6(1):8–19. doi: 10.1111/j.1476-5381.1951.tb00614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ERSPAMER V. Pharmacological studies on enteramine (5-hydroxytryptamine) IX. Influence of sympathomimetic and sympatholytic drugs on the physiological and pharmacological actions of enteramine. Arch Int Pharmacodyn Ther. 1953 Apr;93(3-4):293–316. [PubMed] [Google Scholar]
- GADDUM J. H., HAMEED K. A. Drugs which antagonize 5-hydroxytryptamine. Br J Pharmacol Chemother. 1954 Jun;9(2):240–248. doi: 10.1111/j.1476-5381.1954.tb00848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaddum J. H., Peart W. S., Vogt M. The estimation of adrenaline and allied substances in blood. J Physiol. 1949 Jun 15;108(4):467–481. doi: 10.1113/jphysiol.1949.sp004350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JACOB J., CUGURRA F. [Action of 1-benzyl-2,5-dimethylserotonin (B.A.S.) on the tension effects of serotonin and on the cardiac activity in the dog and in the rabbit]. Arch Int Pharmacodyn Ther. 1960 Jan 1;123:362–376. [PubMed] [Google Scholar]
- MCCUBBIN J. W., PAGE I. H., SALMOIRAGHI G. C. Cardiovascular and respiratory response to intravenous serotonin in rats. J Pharmacol Exp Ther. 1956 Dec;118(4):477–481. [PubMed] [Google Scholar]
- PAGE I. H. Serotonin (5-hydroxytryptamine); the last four years. Physiol Rev. 1958 Apr;38(2):277–335. doi: 10.1152/physrev.1958.38.2.277. [DOI] [PubMed] [Google Scholar]
- POWELL C. E., SLATER I. H. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther. 1958 Apr;122(4):480–488. [PubMed] [Google Scholar]
- SALMOIRAGHI G. C., MCCUBBIN J. W., PAGE I. H. Effects of d-lysergic acid diethylamide and its brom derivative on cardiovascular responses to serotonin and on arterial pressure. J Pharmacol Exp Ther. 1957 Feb;119(2):240–247. [PubMed] [Google Scholar]
- SHAW E. N., WOOLLEY D. W. Methylserotonins as potent antimetabolites of serotonin active both in vitro and in vivo. J Pharmacol Exp Ther. 1956 Feb;116(2):164–176. [PubMed] [Google Scholar]